According to a new Weibo post by Huawei official He Gang, we’ll see the brand’s first smartwatch with blood pressure monitoring in the second half of this year. Based on the shared info, Huawei’s upcoming smartwatch with ECG (electrocardiogram) monitoring has already passed registration as a medical device in China and is now starting clinical trials in medical institutions across the country.
Huawei plans to incorporate hypertension management and coronary heart disease screening alongside smart body temperature health measurement. Huawei’s ECG reader will rely on a combination of PPG and ACC data to detect early signs of heart disease. Huawei is reportedly working on its Watch 3 smartwatch which should be announced alongside the P50 series. So far, we’ve seen rumors that the watch will boot HarmonyOS and will pack eSIM functionality.